Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

\

Sernova Corp. (T:SVA)

Business Focus: Medical Devices & Implants

INK Edge Outlook

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for SVA within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Sep 28, 2022 07:30 ET
Sernova to Participate in the Roth Inaugural Healthcare Opportunities Conference
Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative cell therapeutics, today announced it will be presenting at the upcoming Roth Inaugural Healthcare Opportunities Conference being held...
Read full article
Sep 22, 2022 07:30 ET
Sernova Announces Full Exercise of Share Purchase Warrants Expiring September 22, 2022
Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE / XETRA:PSH), a clinical-stage company and leader in regenerative cell therapeutics, today announced that all remaining share purchase warrants related to the 2020 private placement, expiring on September...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.50
--
--
Price to Sales - TTM
--
2.03
4.54
Price to Book - most recent quarter
6.53
6.53
1.83
Price to Cash Flow per share - TTM
--
0.06
10.24
Price to Free Cash Flow per share - TTM
--
--
15.03
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 2022149,83578,145
Aug 31, 202271,690-72,960
Aug 15, 2022144,65055,810
See Short Report

Business Summary

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution

Sernova Corp. is a Canada-based clinical-stage regenerative medicine therapeutics company. The Company is focused on developing and commercializing regenerative medicine therapeutics, including its Cell Pouch and associated technologies, including therapeutic cells and local cellular immune protection. The Cell Pouch is a scalable and implantable medical device. The Cell Pouch is designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of multiple chronic diseases, such as diabetes, hemophilia and thyroid disease. Its Cell Pouch combines with immune protected therapeutic cells, offers a protection from immune system attack. Its regenerative medicine therapeutic approach provides cell therapies, where the cells transplanted within an organ-like the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

See business summary

 

Twitter

Search (past week) for $SVA.CA

  • No tweets found